HEADER TRANSFERASE/DNA 09-JAN-09 3FSI TITLE CRYSTAL STRUCTURE OF A TRYPANOCIDAL 4,4'-BIS(IMIDAZOLINYLAMINO) TITLE 2 DIPHENYLAMINE BOUND TO DNA COMPND MOL_ID: 1; COMPND 2 MOLECULE: REVERSE TRANSCRIPTASE DOMAIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: REVERSE TRANSCRIPTASE DOMAIN: UNP RESIDUES 144-398; COMPND 5 SYNONYM: RT; COMPND 6 EC: 2.7.7.49; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: 5'-D(*CP*TP*TP*AP*AP*TP*TP*C)-3'; COMPND 10 CHAIN: G; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: 5'-D(P*GP*AP*AP*TP*TP*AP*AP*G)-3'; COMPND 14 CHAIN: B; COMPND 15 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MOLONEY MURINE LEUKEMIA VIRUS; SOURCE 3 ORGANISM_COMMON: VIRUS; SOURCE 4 ORGANISM_TAXID: 11801; SOURCE 5 GENE: MOMLV, POL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 MOL_ID: 3; SOURCE 14 SYNTHETIC: YES KEYWDS TRANSFERASE/DNA MMLV RT, PROTEIN-DNA COMPLEX, DRUG-DNA COMPLEX, CD27, KEYWDS 2 ANTITRYPANOSOMAL, DNA INTEGRATION, DNA RECOMBINATION, KEYWDS 3 NUCLEOTIDYLTRANSFERASE, TRANSFERASE, TRANSFERASE-DNA COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR L.S.GLASS,M.M.GEORGIADIS,K.D.GOODWIN REVDAT 5 06-SEP-23 3FSI 1 REMARK DBREF LINK REVDAT 4 01-NOV-17 3FSI 1 REMARK REVDAT 3 03-DEC-14 3FSI 1 HET HETNAM VERSN REVDAT 2 07-JUL-09 3FSI 1 JRNL REVDAT 1 19-MAY-09 3FSI 0 JRNL AUTH L.S.GLASS,B.NGUYEN,K.D.GOODWIN,C.DARDONVILLE,W.D.WILSON, JRNL AUTH 2 E.C.LONG,M.M.GEORGIADIS JRNL TITL CRYSTAL STRUCTURE OF A TRYPANOCIDAL JRNL TITL 2 4,4'-BIS(IMIDAZOLINYLAMINO)DIPHENYLAMINE BOUND TO DNA. JRNL REF BIOCHEMISTRY V. 48 5943 2009 JRNL REFN ISSN 0006-2960 JRNL PMID 19405506 JRNL DOI 10.1021/BI900204W REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 91.6 REMARK 3 NUMBER OF REFLECTIONS : 34619 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.231 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.600 REMARK 3 FREE R VALUE TEST SET COUNT : 1727 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1982 REMARK 3 NUCLEIC ACID ATOMS : 325 REMARK 3 HETEROGEN ATOMS : 45 REMARK 3 SOLVENT ATOMS : 228 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.80700 REMARK 3 B22 (A**2) : 3.13800 REMARK 3 B33 (A**2) : 2.66900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.005 REMARK 3 BOND ANGLES (DEGREES) : 1.263 REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.369 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.177 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.866 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.849 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : 52.54 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : CNS_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : CNS_TOPPAR:DNA-RNA_REP.PARAM REMARK 3 PARAMETER FILE 3 : CNS_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : ACT.PAR REMARK 3 PARAMETER FILE 5 : CDX.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : CNS_TOPPAR:PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : CNS_TOPPAR:DNA-RNA.TOP REMARK 3 TOPOLOGY FILE 3 : CNS_TOPPAR:WATER.TOP REMARK 3 TOPOLOGY FILE 4 : ACT.TOP REMARK 3 TOPOLOGY FILE 5 : CDX.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3FSI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-09. REMARK 100 THE DEPOSITION ID IS D_1000050987. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-NOV-06 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.008001 REMARK 200 MONOCHROMATOR : ROSENBAUM-ROCK HIGH-RESOLUTION REMARK 200 DOUBLE-CRYSTAL REMARK 200 OPTICS : ROSENBAUM-ROCK VERTICAL FOCUSING REMARK 200 MIRROR, LN2 COOLED FIRST CRYSTAL, REMARK 200 SAGITAL FOCUSING 2ND CRYSTAL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 35935 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 4.600 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 24.6770 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.90 REMARK 200 R MERGE FOR SHELL (I) : 0.35500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1ZTW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.70 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, MAGNESIUM ACETATE, ADA PH REMARK 280 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 26.87150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 72.79600 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 26.87150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 72.79600 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: TWO PROTEIN MOLECULES JOINED BY A 16MER-BP DOUBLE STRAND OF REMARK 300 DNA, WITH CD27 BOUND TO BOTH 5'-AATT SITES. ONE ASYMMETRIC UNIT REMARK 300 RETAINS ONE HALF OF THE 16MER-BP, ONE PROTEIN AND ONE BOUND LIGAND. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: HEXAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, G, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 107.48600 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 145.59200 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 102 REMARK 465 LYS A 103 REMARK 465 PRO A 104 REMARK 465 GLY A 105 REMARK 465 THR A 106 REMARK 465 ASN A 107 REMARK 465 ASP A 108 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 64 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 41 114.12 -168.34 REMARK 500 MET A 177 108.44 70.48 REMARK 500 SER A 180 -92.80 -20.42 REMARK 500 VAL A 223 -104.71 59.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 378 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 379 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 380 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 381 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ACT A 382 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MWB G 9 DBREF 3FSI A 24 278 UNP P03355 POL_MLVMO 144 398 DBREF 3FSI G 1 8 PDB 3FSI 3FSI 1 8 DBREF 3FSI B 9 16 PDB 3FSI 3FSI 9 16 SEQRES 1 A 255 THR TRP LEU SER ASP PHE PRO GLN ALA TRP ALA GLU THR SEQRES 2 A 255 GLY GLY MET GLY LEU ALA VAL ARG GLN ALA PRO LEU ILE SEQRES 3 A 255 ILE PRO LEU LYS ALA THR SER THR PRO VAL SER ILE LYS SEQRES 4 A 255 GLN TYR PRO MET SER GLN GLU ALA ARG LEU GLY ILE LYS SEQRES 5 A 255 PRO HIS ILE GLN ARG LEU LEU ASP GLN GLY ILE LEU VAL SEQRES 6 A 255 PRO CYS GLN SER PRO TRP ASN THR PRO LEU LEU PRO VAL SEQRES 7 A 255 LYS LYS PRO GLY THR ASN ASP TYR ARG PRO VAL GLN ASP SEQRES 8 A 255 LEU ARG GLU VAL ASN LYS ARG VAL GLU ASP ILE HIS PRO SEQRES 9 A 255 THR VAL PRO ASN PRO TYR ASN LEU LEU SER GLY LEU PRO SEQRES 10 A 255 PRO SER HIS GLN TRP TYR THR VAL LEU ASP LEU LYS ASP SEQRES 11 A 255 ALA PHE PHE CYS LEU ARG LEU HIS PRO THR SER GLN PRO SEQRES 12 A 255 LEU PHE ALA PHE GLU TRP ARG ASP PRO GLU MET GLY ILE SEQRES 13 A 255 SER GLY GLN LEU THR TRP THR ARG LEU PRO GLN GLY PHE SEQRES 14 A 255 LYS ASN SER PRO THR LEU PHE ASP GLU ALA LEU HIS ARG SEQRES 15 A 255 ASP LEU ALA ASP PHE ARG ILE GLN HIS PRO ASP LEU ILE SEQRES 16 A 255 LEU LEU GLN TYR VAL ASP ASP LEU LEU LEU ALA ALA THR SEQRES 17 A 255 SER GLU LEU ASP CYS GLN GLN GLY THR ARG ALA LEU LEU SEQRES 18 A 255 GLN THR LEU GLY ASN LEU GLY TYR ARG ALA SER ALA LYS SEQRES 19 A 255 LYS ALA GLN ILE CYS GLN LYS GLN VAL LYS TYR LEU GLY SEQRES 20 A 255 TYR LEU LEU LYS GLU GLY GLN ARG SEQRES 1 G 8 DC DT DT DA DA DT DT DC SEQRES 1 B 8 DG DA DA DT DT DA DA DG HET ACT A 378 4 HET ACT A 379 4 HET ACT A 380 4 HET ACT A 381 4 HET ACT A 382 4 HET MWB G 9 25 HETNAM ACT ACETATE ION HETNAM MWB N1-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)-N4-(4-((4,5-DIHYDRO- HETNAM 2 MWB 1H-IMIDAZOL-2-YL)AMINO)PHENYL)BENZENE-1,4-DIAMINE HETSYN MWB CD27 FORMUL 4 ACT 5(C2 H3 O2 1-) FORMUL 9 MWB C18 H21 N7 FORMUL 10 HOH *228(H2 O) HELIX 1 1 THR A 24 PHE A 29 1 6 HELIX 2 2 TRP A 33 GLY A 38 1 6 HELIX 3 3 SER A 67 GLN A 84 1 18 HELIX 4 4 LEU A 115 LYS A 120 1 6 HELIX 5 5 ASN A 131 SER A 137 1 7 HELIX 6 6 ALA A 154 LEU A 158 5 5 HELIX 7 7 SER A 164 ALA A 169 5 6 HELIX 8 8 ASN A 194 LEU A 207 1 14 HELIX 9 9 LEU A 207 HIS A 214 1 8 HELIX 10 10 SER A 232 GLY A 251 1 20 SHEET 1 A 3 LEU A 87 CYS A 90 0 SHEET 2 A 3 GLN A 182 TRP A 185 -1 O THR A 184 N VAL A 88 SHEET 3 A 3 PHE A 170 GLU A 171 -1 N PHE A 170 O LEU A 183 SHEET 1 B 4 ILE A 218 TYR A 222 0 SHEET 2 B 4 ASP A 225 ALA A 230 -1 O ALA A 229 N ILE A 218 SHEET 3 B 4 TRP A 145 ASP A 150 -1 N LEU A 149 O LEU A 226 SHEET 4 B 4 GLN A 260 GLN A 263 -1 O GLN A 263 N TYR A 146 SHEET 1 C 2 GLN A 265 TYR A 268 0 SHEET 2 C 2 TYR A 271 LYS A 274 -1 O LEU A 273 N VAL A 266 LINK O3' DC G 8 P DG B 9 1555 2765 1.60 SITE 1 AC1 2 GLN A 91 SER A 92 SITE 1 AC2 6 ASP A 153 ALA A 154 PHE A 155 PHE A 156 SITE 2 AC2 6 GLN A 190 HOH A 303 SITE 1 AC3 5 ILE A 125 PRO A 127 THR A 197 HOH A 283 SITE 2 AC3 5 HOH A 431 SITE 1 AC4 4 MET A 66 GLU A 171 TRP A 172 ARG A 173 SITE 1 AC5 4 THR A 24 TRP A 25 PHE A 29 ARG A 241 SITE 1 AC6 10 DA B 10 DA B 11 DT B 12 DT B 13 SITE 2 AC6 10 DA B 14 DA G 4 DA G 5 DT G 6 SITE 3 AC6 10 DT G 7 DC G 8 CRYST1 53.743 145.592 46.570 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018607 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006869 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021473 0.00000